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Type III secretion (T3S) is an export pathway used by Gram-negative pathogenic bacteria to inject bacterial proteins into the
cytosol of eukaryotic host cells. This pathway is characterized by (i) a secretion nanomachine related to the bacterial ﬂagellum,
but usually topped by a stiﬀ needle-like structure; (ii) the assembly in the eukaryotic cell membrane of a translocation pore formed
by T3S substrates; (iii) a non-cleavable N-terminal secretion signal; (iv) T3S chaperones, assisting the secretion of some substrates;
(v) a control mechanism ensuring protein delivery at the right place and time. Here, we review these diﬀerent aspects focusing in
open questions that promise exciting ﬁndings in the near future.
 2005 Published by Elsevier B.V. on behalf of the Federation of European Microbiological Societies.
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Type III secretion (T3S) systems are protein export
devices essential for the interaction between Gram-neg-
ative bacteria and their eukaryotic hosts. These systems
are present in many pathogenic bacteria for animals and
plants, but also in endosymbionts. Bacteria use T3S to
translocate proteins across lipid membranes and to in-
ject some of them, called ‘‘eﬀectors’’, into the cytoplasm
of host cells. Inside the eukaryotic cell cytoplasm, the
eﬀectors thwart or hijack host cell signaling to the ben-
eﬁt of the bacteria, in the case of pathogens, or both
organisms, in the case of symbionts.0378-1097/$22.00  2005 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.femsle.2005.08.036
* Corresponding author. Tel.: + 41 61 267 2121; fax: +41 61 267
2118.
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unibas.ch (G.R. Cornelis).
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Microbiology and Infection, Armstrong Road, Flowers Building,
London SW7 2AZ, United Kingdom.With the sequencing of bacterial genomes, the list of
species known to harbour T3S systems has become too
long to be listed exhaustively (Table 1). Among the ani-
mal pathogens, T3S have been most intensively studied
in Yersinia spp., Salmonella spp., Shigella spp., Pseudo-
monas aeruginosa, and enteropathogenic Escherichia coli
(EPEC) and enterohaemorrhagic E. coli (EHEC). The
most studied T3S system from a plant pathogen is prob-
ably that of P. syringae, but this secretion system has
also been identiﬁed and studied in several other plant
pathogens.
The T3S substrates are synthesized in the bacterial
cytoplasm and are secreted by a nano-machine, called
injectisome, across the bacterial inner membrane, peri-
plasm and the bacterial outer membrane. Some of these
secreted proteins, called ‘‘translocators’’ insert in the
host cell plasma membrane and mediate the transloca-
tion of the eﬀectors across eukaryotic plasma or vacuo-
lar membranes into the host cell cytosol. Secretion of
the eﬀectors across the bacterial membranes and trans-
location through the eukaryotic membrane is thoughtation of European Microbiological Societies.
Table 1
T3S systems of bacterial pathogens for mammals
Bacterium Diseases T3S system(s) function(s)a
Aeromonas spp. Opportunistic human pathogen causing gastroenteritis and septicemia (A.
hydrophila)
Asc
Furunculosis in salmonids (A. salmonicida) Cytotoxicity on ﬁsh cells
Bordetella spp. Respiratory tract infections, whooping cough (B.pertussis, B. parapertussis) Bsc
Infection of four-legged animals (B. bronchiseptica) Establishment of long term infection
Downregulation of inﬂammation
Burkholderia spp. Melioidosis: pneumonia and skin abcesses
(B. pseudomallei)
Bp1 (B. pseudomallei)
?
Glanders (B. mallei) Bp2 (B. pseudomallei; B. mallei; B. thailandensis)
?
Pulmonar infection of cystic ﬁbrosis patients (B. cepacia complex) Bp3 (B. pseudomallei; B. mallei; B. thailandensis)
Survival and escape from macrophage vacuoles; Invasion of
non-phagocytic cells
Bcsc (B. cepacia complex)
Important for virulence in the murine model
Chlamydiaceae Sexual transmitted diseases, trachoma (C. trachomatis) Sct
Pneumonia, atherosclerosis (C. pneumoniae) Cell internalization
Chromobacterium violaceum Sporadic infections in humans and mammals resulting in fulminant septicaemia that
resembles melidiosis
Civ
Similar to Inv (SPI-1) and Mxi-Spa
Csa
Similar to Ssa (SPI-2)
Citrobacter rodentium Murine colonic hyperplasia, attaching/eﬀacing lesions 1 Esc
Adhesion to the intestinal epithelium
Cytoskeleton rearrangements
Desulfovibrio vulgaris Implicated in ulcerative colitis Dsc
?
Edwardsiella tarda Hemorrhagic septicemia in ﬁshes, diverse infections in humans Eds
Edwradsiella ictaluri Survival and replication in ﬁsh phagocytes
Enteropathogenic Escherichia coli
(EPEC) and enterohemorrhagic
E. coli (EHEC)
Diarrhoea, attachment/eﬀacement lesion (EPEC) Esc
Diarrhoea, attachment/eﬀacement lesion, haemorrhagic colitis (EHEC) Colonization
Cell attachment
Actin remodelling
Pedestal formation
Pseudomonas aeruginosa Pneumonias and chronic bronchopneumonia in patients with cystic ﬁbrosis;
ulcerative keratitis
Psc
Cytotoxicity
Block phagocytosis
Line missing
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L.J. Mota et al. / FEMS Microbiology Letters 252 (2005) 1–10 3to occur in one step. Secretion of some of these proteins
is assisted in bacteria by specialized and strictly cyto-
solic T3S chaperones. Besides the eﬀectors and translo-
cators, T3S systems also secrete components of the
injectisome and regulatory proteins. The whole process
is tightly controlled to allow eﬃcient secretion of pro-
teins at the right place and time.
The T3S pathway is also used for the export of ﬂagel-
lar proteins. Injectisomes and ﬂagellae are evolutionary
related and share a remarkably similar basal body struc-
ture. In this review, we will focus on the injectisome
function. We apologize to the authors of many impor-
tant contributions that could not be cited here owing
to space restrictions.2. The injectisome nanomachine
The electron microscopy (EM) visualization of the
ﬁrst injectisome, from Salmonella enterica, was reported
in 1998 [1]. Afterwards, EM studies allowed the visuali-
zation of the complete injectisomes from Shigella ﬂex-
neri [2] and EPEC [3]. Recently, cryo-EM analyses
allowed the visualization at 17 A˚ resolution of the S. ent-
erica injectisome [4]. All these studies indicate that the
injectisome nanomachine consists of two distinct parts
(Fig. 1): (i) a cylindrical base, similar to the ﬂagellar ba-
sal body, composed of two pairs of rings that span the
inner and outer bacterial membranes, joined together
by a rod; (ii) the base is physically linked to a hollow,
elongated, and stiﬀ needle-like structure. In EPEC, a
long ﬂexible structure, called the EspA ﬁlament, extends
the needle (Fig. 1) [3,5]; in plant pathogens, a long and
thin structure, called the Hrp pilus extends from the base
of the structure [6]. It is generally thought that the
injectisome serves as a hollow conduit for travelling of
the secreted proteins. Indeed, EM experiments provide
evidence for the extrusion of the P. syringae eﬀector pro-
teins AvrPto and HrpZ from the tip of the Hrp pilus [6].
The proper assembly of the injectisome requires
around 25 proteins, generally encoded by genes clus-
tered in one locus. The precise function and localization
of these proteins is only known for a reduced set. The
inner pair of rings of the base is made of at least two
proteins (called PrgH and PrgK in S. enterica [7], and
MxiG and MxiJ in Shigella [2,8]) (Fig. 1). The outer pair
of rings, associated with the outer membrane and the
peptidoglycan layer, is made of proteins of the secretin
family (InvG in Salmonella [7], MxiD in Shigella [2,8],
and YscC in Yersinia [9]) (Fig. 1). Cryo-EM observa-
tions and image processing analysis revealed that the
base is hollow, and that an ‘‘inner rod’’ channel, made
of PrgJ, in Salmonella, is mounted upon needle assembly
[4]. Besides the proteins that constitute the structural
base of the injectisomes, a set of inner membrane and
cytoplasmic proteins are highly conserved throughout
Fig. 1. The T3S injectisome nanomachine. Schematic drawing of T3S injectisomes representative of Yersinia, Salmonella and Shigella (left part), and
enteropathogenic E. coli (EPEC) (right part). The schemes show the needle (prolonged by the EspA ﬁlament, in the case of EPEC) protruding from
the bacterial membrane, and the basal body spanning the outer membrane (OM), the peptidoglycan layer (PG) and the inner membrane (IM) of the
bacterium. The constituents of the injectisome whose localization is known are indicated. The colour code indicates the protein in relation to the
bacteria where they are expressed. The main components of the needle (YscF, PrgI, MxiH, EscF), of the two rings spanning the outer membrane
(YscC, InvG, MxiD secretins), the two rings in close proximity to the inner membrane (PrgH, PrgK, MxiG, MxiJ), and an inner rod mounted upon
needle assembly (PrgJ) are outlined. There is also evidence that the YscP ruler is associated with the needle [11], and the same might be true for InvJ
and Spa32. Also schematically shown (red circle) is the ATPase that is thought to energize T3S.
4 L.J. Mota et al. / FEMS Microbiology Letters 252 (2005) 1–10all T3S systems, including the ﬂagellum. These include
the ATPase (YscN in Yersinia) that should be the energy
source for the apparatus.
The injectisome needle is a straight hollow tube made
by the polymerization of a major subunit (PrgI in Sal-
monella [1], MxiH in Shigella [2,8], YscF in Yersinia
[10], and EscF in EPEC [3]) (Fig. 1). The injectisome
needle length is deﬁned, varying between 45 and 80 nm
according to the bacterial species. Proteins called YscP,
in Yersinia [11], Spa32, in Shigella [12], and InvJ, in Sal-
monella [7], control the needle length (Fig. 1). The pre-
cise needle length seems to have been evolutionary
adjusted in relation to the dimensions of other structures
at the bacterial surface, like adhesins [13], or lipopoly-
saccharide [14]. In Yersinia, deletions and insertions in
YscP lead to shorter and longer needles, respectively.
This revealed a linear correlation between the lengths
of the needle and YscP, indicating that YscP acts as a
molecular ruler. Export of needle subunit proteins are
allowed until the needle reaches the length of the ex-
tended YscP protein. Then, YscP triggers a substrate
speciﬁcity switch, which stops YscF secretion and makes
the apparatus ready for eﬀector secretion [11]. There is
genetic evidence that this substrate speciﬁcity switch
involves an interaction between YscP and YscU [15],
an inner membrane protein. In addition, genetic andbioinformatics analyses indicate that a domain within
the C-terminal of YscP mediates the substrate speciﬁcity
switch, and that this domain is conserved among several
other YscP orthologues [16]. There is structural evidence
that the injectisome base undergoes conformational
changes upon needle assembly [4]. These conformational
changes may be a consequence of the substrate speciﬁc-
ity switch mechanism, but this still remains to be proven.
Thus, there is likely a complex network of protein inter-
actions, mostly still to be unraveled, and subtle confor-
mational changes that ensures a proper needle assembly.3. The translocators: the injectisome-host cell connection?
Translocation of the eﬀectors across the eukaryotic
cell membrane requires a set of proteins called the
‘‘translocators’’ that are also T3S substrates [17–21].
Generally, there are three translocators (YopB, YopD
and LcrV in Yersinia), two of them (YopB,YopD) with
clear hydrophobic domains and the other (LcrV) being
an hydrophilic protein. In agreement with their hydro-
phobic nature, YopB and YopD were shown to insert
in the membrane of erythrocytes [22] and to form a pore
in erythrocytes [19] and in nucleated cells [23], which
presumably mediates eﬀector translocation. The third
L.J. Mota et al. / FEMS Microbiology Letters 252 (2005) 1–10 5translocator, LcrV, is required for pore formation [24],
but it does not insert in membranes of infected erythro-
cytes [22]. These observations suggest a model in which
the hydrophilic translocator, acting as an extracellular
chaperone, helps the hydrophobic translocators to inte-
grate in the eukaryotic plasma membrane and to form
there a pore (Fig. 2). This model is supported by similar
observations made in P. aeruginosa [25], Shigella [26,27]
and EPEC [28], but diﬀerent aspects still need to be chal-
lenged. Firstly, the exact composition, stoichiometry
and structure of the pore remain to be elucidated. Sec-
ondly, the T3S translocation process is thought to be a
one-step mechanism, which implies that the pore and
the injectisome must be physically connected. However,
an interaction between translocator proteins and the
needle subunits has never been shown. The only possible
exception is in the case of EPEC, where the YopB
homologue, EspB, seems to interact with EscF, the nee-
dle subunit, via the EspA ﬁlament [3,5,29]. If counter-
parts of YopB/YopD are present in all bacteria
carrying T3S systems, the situation regarding LcrV itFig. 2. The T3S traslocation pore. A model for formation of the T3S
translocation pore is schematically shown. T3S is triggered upon
contact with the eukaryotic cell lipid membrane. The translocators
(two hydrophobic proteins and one hydrophilic protein) should have
secretion priority, but this has never been experimentally demon-
strated. Then, the two hydrophobic translocators (in orange) insert
and form a pore in the host cell lipid membrane in a process assisted by
the hydrophilic translocator (in red). The structure and stoichiometry
of the pore are unknown. The hetero-heptameric pore structure shown
is purely hypothetical. It is also unknown if the hydrophilic translo-
cator binds to the assembled pore and/or needle.is more complex. The P. aeruginosa PcrV protein is
homologous to LcrV, and even complements an LcrV
deﬁciency [20]. However, in Salmonella and Shigella,
there is no LcrV homologous protein but IpaD, in Shi-
gella, and SipD, in Salmonella, may play an identical
role with respect to eﬀector translocation and pore for-
mation [27]. EspA apparently plays a similar role, in
the sense that it does not insert in membranes but it is
required for pore formation. It is thus very tempting
to speculate whether LcrV/PcrV/IpaD/SipD would have
a similar role as EspA in linking the pore to the needle.
Finally, the translocators must have a secretion priority
related to their function. It is noteworthy that LcrV was
detected at the bacterial surface before secretion of the
eﬀectors is triggered [20].4. The T3S signal sequence: a peptide or not a peptide?
At the time of the ﬁrst observations of T3S, it
appeared that substrate recognition occurs by a non-
cleavable N-terminal signal [30]. Later, the minimal
N-terminal region required for secretion was shown to
be around 15 residues for diﬀerent Yersinia T3S
substrates [31,32]. However, the exact molecular deter-
minants that allow the injectisome to recognize the
T3S substrates among all the other bacterial proteins
are still a matter of debate. The observation that led
to this controversy was the ﬁnding that no mutations
could be identiﬁed that speciﬁcally abolished secretion
of the Yersinia proteins YopE and YopN, when their
N-terminus is fused to a reporter protein [31]. These re-
sults suggested that the secretion signal is encoded in the
mRNA rather than in the peptide sequence [31]. Today,
two orders of evidence indicate that this mRNA signal,
if it exists, is not the only T3S recognition motif. First,
frameshift mutations that completely alter the amino
acid sequence of residues 2-11 of YopE, but leave the
mRNA sequence essentially intact, abolished secretion
of full-length YopE [33]. In contrast, synonymous muta-
tions in the ﬁrst 11 codons of yopE, which alter the
yopE mRNA sequence but not the YopE amino acid se-
quence, do not aﬀect YopE secretion [33]. Secondly, and
most importantly, the signal mRNA hypothesis predicts
that T3S would be co-translational, and it has been dem-
onstrated in Shigella that some pre-synthesized and
stored eﬀectors are secreted upon addition of an artiﬁ-
cial inducer of secretion [34]. In contrast, reports favor-
ing a role of an mRNA signal on T3S have been
published in recent years. For example, it was reported
that synonymous mutations in yopE prevent T3S secre-
tion of hybrid proteins [35].
Both hypotheses are hard to reconcile, but so far a
deﬁned model that could explain the recognition mech-
anism by which T3S substrates are selectively engaged
by the injectisome is lacking. Studies on secretion by
6 L.J. Mota et al. / FEMS Microbiology Letters 252 (2005) 1–10the bacteria ﬂagellum indicate that the secretion signal
might be a disordered N-terminus, but it is diﬃcult to
imagine how such an unstructured element would be
recognized by the injectisome.5. The multiple roles of T3S chaperones
Secretion of some, but not all, T3S substrates requires
the assistance in the bacterial cytoplasm of a particular
type of chaperones, which are a hallmark of T3S. They
are low molecular mass acidic proteins (ca. 15 kDa) that
speciﬁcally interact with only one or a few T3S sub-
strates and are required for proper secretion of their
cognate substrate.
There are examples of proteins requiring T3S chap-
erones among the diﬀerent types of T3S substrates.
Chaperones of eﬀectors have been most studied ones.
The archetype of the T3S chaperones is SycE from
Yersinia [36]. SycE is a dimer which binds to the N-
terminal region of YopE. This seems to be the case
for most if not all the eﬀector chaperones. In the ab-
sence of SycE, YopE is unstable and rapidly degraded
[36]. The reason why SycE is necessary to stabilize
YopE became apparent only recently. SycE is neces-
sary to mask an aggregation-prone region between
amino acids 50–77 of YopE, since the presence of this
domain creates the requirement of SycE for YopE
secretion and stabilization [37]. This domain is not re-
quired for the catalytic activity of YopE but is rather
involved in the proper targeting of YopE to host cell
membranes [38]. Although YopE deleted of amino
acids 50–77 still exerts its long-term toxic eﬀect on
eukaryotic cells [37,38], it is likely that such an activ-
ity is not eﬃcient in the context of the infection. Thus,
SycE protects a region of YopE that is required for its
function but that hampers its secretion. In addition,
SycE was also shown in some conditions to be re-
quired for YopE recognition by the injectisome
[33,39]. A strong argument in favor of a targeting role
for T3S chaperones comes from the observation that
the Salmonella eﬀectors SptP and SopE, in the absence
of their chaperone binding sites, are secreted through
the ﬂagellar T3S rather than through the injectisome
[40]. A targeting role could also apply to Spa15, an
eﬀector chaperone from Shigella. In the absence of
this chaperone, post-translational secretion is abol-
ished but co-translational secretion is unaﬀected [34].
In this case, the chaperone could not only pilot the
T3S substrate to the T3S apparatus but it could also
maintain it in a secretion competent state. However,
it is diﬃcult to conclude that the role of eﬀector chap-
erones is to prevent folding of their partner. Indeed,
SycE bound to YopE does not abrogate the catalytic
activity of YopE [41] and hence, presumably does not
prevent its folding. Similar observations were madefor the complexes between EPEC eﬀector Tir and its
chaperone, and the Salmonella eﬀector SopB and its
chaperone SigE [42]. However, this does not exclude
that in some cases chaperones may facilitate export
by preventing folding. It was indeed shown that SycE
allows secretion of YopE-DHFR hybrid proteins
which can otherwise not be secreted presumably be-
cause they fold irreversibly [43].
The two hydrophobic translocators share one com-
mon chaperone. In the Yersinia Ysc-Yop injectisome,
YopB and YopD share the SycD chaperone [44]. In
the Shigella injectisome, the hydrophobic translocators
IpaB and IpaC share the IpgC chaperone [45]. IpgC sta-
bilizes IpaB and IpaC and prevents their premature
association in the cytoplasm of Shigella cells [45]. SycD
masks the hydrophobic domains in YopB, neutralizes
their potential toxicity, and may prevent premature
association of YopB/YopD with LcrV [44]. Some pro-
teins that belong to the distal part of the injectisome also
have a cytosolic chaperone but their role is even less
documented than for the others. The chaperones were
also shown to be involved T3S control (see below).
Most T3S substrates exert their action at speciﬁc
sites in the host eukaryotic cell. Their design must have
been shaped by two evolutionary pressures: their pre-
cise function/activity at certain localization and time,
and their need to be secreted/translocated through
two or three lipid membranes. The diverse functions
of T3S chaperones could reﬂect an evolutionary con-
ﬂict between these two pressures, which might have
also created the need for the chaperone in some cases,
but not in others.6. Regulation: what makes T3S work when it must work
T3S is regulated at diﬀerent levels. Transcription of
the genes encoding the secretion apparatus is regulated
by transcriptional regulators, in response to diﬀerent
environmental stimuli. This is achieved by the action
of classical regulatory proteins such as AraC-like tran-
scriptional activators, histone-like proteins and two-
component regulatory systems. This level of control is
thought to ensure expression and assembly of the injecti-
some and a certain level of expression of T3S substrates.
The activity of the injectisome is itself tightly regulated,
and secretion only occurs when a speciﬁc signal triggers
it, which in turn boosts expression of T3S genes. Based
on solid evidence from Yersinia and Shigella [17,46,47],
the signal that triggers T3S is commonly viewed as
contact with a host cell (Fig. 3). The mechanisms by
which the activity of the injectisome remains blocked
in the absence of triggering are not totally understood.
In Yersinia, at least ﬁve proteins, YopN and its chaper-
ones SycN and YscB [48,49], TyeA [50] and LcrG [51]
are required for this control and for proper eﬀector
Fig. 3. Regulation of T3S. A general model on the mechanisms that were described to control T3S is shown. The model summarizes information
from diﬀerent T3S systems; it does not mean that all mechanisms are operative in a single bacterium. In T3S systems, a ﬁrst response to speciﬁc host
environmental conditions ensures injectisome assembly and a certain expression level of T3S eﬀectors. However, secretion only occurs when a speciﬁc
signal triggers T3S. In the absence of contact, secretion is prevented by a multiprotein complex of T3S regulators that somehow blocks the access of
T3S substrates to the injectisome. In non-secreting conditions, transcription from T3S substrates promoters is limited. This has been shown to be due
to the indirect and uncharacterized action of a negative regulator of T3S transcription and to the inability of an AraC-like transcription activator to
have high-aﬃnity access to the T3S promoters. Upon contact with the eukaryotic host cell plasma membrane, the complex blocking the access to the
injectisome is disassembled and secretion starts. This leads not only to the secretion of T3S eﬀectors but also of some T3S regulators. In addition, the
T3S chaperones are now free in the cytoplasm. The consequences are that the negative regulator of T3S transcription cannot exert its action any more
(because is secreted) and the AraC-like transcription activator forms a high-aﬃnity complex for T3S promoters with the now free T3S translocator
chaperones, boosting transcription and expression of T3S eﬀector genes. The function of T3S chaperones is far more complex (see text for a
discussion) than what is depicted in this model on T3S control. The injectisome and translocation pore are represented as in Figs. 1 and 2. OM, outer
membrane; PG, peptidoglycan; IM, inner membrane.
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complex, likely in the bacterial cytoplasm, which should
block T3S in non-triggering conditions [52]. LcrG is a
cytosolic protein that interacts with LcrV [53], and its
regulatory role is likely to be related to its action on
LcrV. However, since all proteins are required to
achieve a tight control of secretion, they all must con-
tribute to one complex trigger mechanism (Fig. 3).
Recent reports suggest that the bacteria could sense
cholesterol in eukaryotic cell lipid membranes to trig-
ger T3S. In Shigella, contact haemolysis due to the
insertion of the T3S pore depends on the presence of
cholesterol on the host cell surface, which was related
to the requirement of cholesterol for the bacteria to
trigger T3S [54]. However, it was recently shown that
IpaB and SipB are cholesterol binding proteins and
that T3S eﬀector delivery by Shigella, Salmonella, and
EPEC does not occur into cholesterol-depleted cells[55]. These observations suggest a model in which the
T3S triggering signal is not dependent on host cell con-
tact, but more speciﬁcally requires the assembly of the
translocation pore in the host cell lipid membrane. The
host cell membrane would provide the lipid environ-
ment required for the formation of the pore complex,
which would then be the last injectisome assembly step.
Indeed, if pore assembly is physically linked to the
injectisome, then it can be envisioned that pore forma-
tion would generate conformational changes triggering
T3S of eﬀector proteins. This is in agreement with
observations indicating that the needle tip is the T3S
sensor [8,13].
Another question is how the activity of the injecti-
some boosts the expression of T3S proteins. This has
been shown to happen by at least two mechanisms.
One is the T3S of a regulatory protein (Fig. 3). In
Yersinia, the feed-back control mechanism that keeps
8 L.J. Mota et al. / FEMS Microbiology Letters 252 (2005) 1–10expression of T3S genes at low levels when the injecti-
some is not operating is relieved by the export of the
LcrQ/YscM protein [47]. However, LcrQ/YscM does
act directly to repress transcription and it does not
block the activity of the activator of Yersinia T3S
genes [56]. The second mechanism exploits the free
state of T3S chaperones when the injectisome is active
(Fig. 3). This is the case of SicA, the chaperone of the
Salmonella SPI-1 translocators [57], IpgC, the chaper-
one of the Shigella translocators [58], and of SycD, the
chaperone of the YopB/YopD [59]. Finally, secretion
of T3S substrates was proposed to be hierarchical.
There is certainly a hierarchy of secretion related to
the nature of the T3S substrates. However, a hierarchy
in secretion of T3S eﬀectors is yet to be clearly dem-
onstrated. It has been proposed that the T3S chaper-
ones could set such a hierarchy [37,41]. The
hypothesis is that proteins having a chaperone would
have a secretion-advantage over those not having
one, but the experimental data supporting this model
is minimal.7. Conclusions
Remarkable progress has been achieved in our
understanding of T3S since the experimental discovery
of this sophisticated export pathway in 1994 [17,18].
However, many important questions remain unan-
swered and others arise from the models that are now
proposed. We know what the injectisome looks like
and high deﬁnition cryo-EM pictures have shown in de-
tail its structure before and after needle assembly. We
also know that this needle has a precise length and
why. However, the exact molecular mechanisms by
which the injectisome is assembled, including needle
length control and substrate speciﬁcity switch, have
only begun to be unravelled. Our knowledge of the
function of the about 25 genes encoding the injectisome
is optimistically restricted to around half of them. A
small set of T3S substrates is dedicated to eﬀector trans-
location probably through a pore. But, what is the exact
composition and structure of this pore? How is the pore
connected to injectisome? How is the T3S of the trans-
locators regulated in time? Regarding the secretion sig-
nal there is still a dispute on whether this signal is an
mRNA or a peptide sequence. The chaperones are a
trademark of T3S and have been intensively studied
since its discovery, and we now know the crystal struc-
tures of some of them, but the basic question remains
unanswered: why some T3S substrates require a chaper-
one whereas others do not? We know that T3S requires
a strict regulatory mechanism to allow eﬀector delivery
only at a certain time and at a certain place. The phys-
iological signal that triggers T3S is likely to be host cell
contact, but this has been only shown for Shigella andYersinia. Generally, our knowledge of the mechanisms
that control T3S is limited. Finally, both the setting of
a secretion hierarchy and the role of cholesterol in
T3S triggering or pore formation are recent trendy top-
ics but further studies are required to understand their
possible role in T3S.
In conclusion, the following years in T3S research
promise to be as exciting as the past 15 years. The
incoming and forthcoming studies are expected not only
to result in a better understanding of the system itself,
but also to lead to the discovery of new concepts in
molecular biology, microbiology and biochemistry,
and to ﬁndings that may contribute to the design of
new drugs to combat many important bacterial
pathogens.Acknowledgement
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